AAV-BDNF augments neurogenesis in both the normal adult rat brain and the quinolinic acid lesion model of Huntington's disease

被引：0
|
作者：
Connor, B
Henry, RA
Faull, RLM
Hughes, SM
机构：
[1] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland 1, New Zealand
[2] Univ Auckland, Dept Anat & Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand
来源：
EXPERIMENTAL NEUROLOGY | 2006年 / 198卷 / 02期
关键词：
D O I：
10.1016/j.expneurol.2006.02.033
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [41] Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington’s disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway
    Priyanka Saroj
    Yashika Bansal
    Raghunath Singh
    Ansab Akhtar
    Rupinder Kaur Sodhi
    Mahendra Bishnoi
    Sangeeta Pilkhwal Sah
    Anurag Kuhad
    Inflammopharmacology, 2021, 29 : 499 - 511
  • [42] Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway
    Saroj, Priyanka
    Bansal, Yashika
    Singh, Raghunath
    Akhtar, Ansab
    Sodhi, Rupinder Kaur
    Bishnoi, Mahendra
    Sah, Sangeeta Pilkhwal
    Kuhad, Anurag
    INFLAMMOPHARMACOLOGY, 2021, 29 (02) : 499 - 511
  • [43] The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease
    Alexi, T
    Hughes, PE
    van Roon-Mom, WMC
    Faull, RLM
    Williams, CE
    Clark, RG
    Gluckman, PD
    EXPERIMENTAL NEUROLOGY, 1999, 159 (01) : 84 - 97
  • [44] Dose-dependent neuroprotective effect of CNTF delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease
    Déglon, N
    Régulier, E
    de Almeida, LP
    Sommer, B
    Aebischer, P
    CELL TRANSPLANTATION, 2003, 12 (03) : 316 - 317
  • [45] Cell Therapy as a Way to Correct Impaired Neurogenesis in the Adult Brain in a Model of Alzheimer’s Disease
    A. V. Chaplygina
    D. Y. Zhdanova
    V. I. Kovalev
    R. A. Poltavtseva
    N. I. Medvinskaya
    N. V. Bobkova
    Journal of Evolutionary Biochemistry and Physiology, 2022, 58 : 117 - 137
  • [46] Cell Therapy as a Way to Correct Impaired Neurogenesis in the Adult Brain in a Model of Alzheimer's Disease
    Chaplygina, A., V
    Zhdanova, D. Y.
    Kovalev, V., I
    Poltavtseva, R. A.
    Medvinskaya, N., I
    Bobkova, N., V
    JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY, 2022, 58 (01) : 117 - 137
  • [47] Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-ΚB pathway
    Bains, Meghna
    Kaur, Jaspreet
    Akhtar, Ansab
    Kuhad, Anurag
    Sah, Sangeeta Pilkhwal
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 934
  • [48] Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington's Disease
    Tsang, T. M.
    Haselden, J. N.
    Holmes, E.
    NEUROCHEMICAL RESEARCH, 2009, 34 (07) : 1261 - 1271
  • [49] Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington’s Disease
    T. M. Tsang
    J. N. Haselden
    E. Holmes
    Neurochemical Research, 2009, 34 : 1261 - 1271
  • [50] Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease
    Sun, M
    Kong, LX
    Wang, XD
    Lu, XG
    Gao, QS
    Geller, AI
    BRAIN RESEARCH, 2005, 1052 (02) : 119 - 129
12345